{
     "PMID": "15174933",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20040719",
     "LR": "20131121",
     "IS": "0735-7044 (Print) 0735-7044 (Linking)",
     "VI": "118",
     "IP": "3",
     "DP": "2004 Jun",
     "TI": "Retrograde amnesia induced by drugs acting on different molecular systems.",
     "PG": "563-8",
     "AB": "The gamma aminobutyric acid-A (GABA-sub(A)) agonist, muscimol, the glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, D-2-amino-5-phosphonopentanoic acid (AP5), and the inhibitor of the extracellularly regulated kinases (ERKs), UO 126, cause retrograde amnesia when administered to the hippocampus. In the present study, the authors found that they all cause retrograde amnesia for 1-trial inhibitory avoidance, not only when infused into the dorsal CA1 region of the hippocampus, but also when infused into the basolateral amygdala or the entorhinal, parietal, and posterior cingulate cortices. The posttraining time course of the effect of each drug was, however, quite different across brain structures. Thus, in all of them, NMDA receptors and the ERK pathway are indispensable for memory consolidation, and GABA-sub(A) receptor activation inhibits memory consolidation: but in each case, their influence is interwoven differently.",
     "CI": [
          "((c) 2004 APA, all rights reserved)"
     ],
     "FAU": [
          "Rossato, Janine I",
          "Bonini, Juliana S",
          "Coitinho, Adriana S",
          "Vianna, Monica R M",
          "Medina, Jorge H",
          "Cammarota, Martin",
          "Izquierdo, Ivan"
     ],
     "AU": [
          "Rossato JI",
          "Bonini JS",
          "Coitinho AS",
          "Vianna MR",
          "Medina JH",
          "Cammarota M",
          "Izquierdo I"
     ],
     "AD": "Centro de Memoria, Departamento de Bioquimica, Institute de Ciencias Basicas da Saude, Universidade Federal do Rio Grande do Sul, Ramiro Barcellos 2600-Anexo, 90035-003 Porto Alegre, RS, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Behav Neurosci",
     "JT": "Behavioral neuroscience",
     "JID": "8302411",
     "RN": [
          "0 (Butadienes)",
          "0 (Enzyme Inhibitors)",
          "0 (GABA Agonists)",
          "0 (Nitriles)",
          "0 (Receptors, N-Methyl-D-Aspartate)",
          "0 (U 0126)",
          "2763-96-4 (Muscimol)",
          "76326-31-3 (2-amino-5-phosphopentanoic acid)",
          "HG18B9YRS7 (Valine)"
     ],
     "SB": "IM",
     "MH": [
          "Amnesia, Retrograde/*chemically induced/physiopathology",
          "Animals",
          "Avoidance Learning/drug effects",
          "Behavior, Animal",
          "Brain/anatomy & histology/*drug effects",
          "Butadienes/adverse effects",
          "Enzyme Inhibitors/adverse effects",
          "GABA Agonists/adverse effects",
          "Male",
          "Muscimol/*adverse effects",
          "Neural Inhibition/drug effects",
          "Nitriles/adverse effects",
          "Rats",
          "Rats, Wistar",
          "Reaction Time/drug effects",
          "Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors",
          "Time Factors",
          "Valine/*adverse effects/*analogs & derivatives"
     ],
     "EDAT": "2004/06/04 05:00",
     "MHDA": "2004/07/20 05:00",
     "CRDT": [
          "2004/06/04 05:00"
     ],
     "PHST": [
          "2004/06/04 05:00 [pubmed]",
          "2004/07/20 05:00 [medline]",
          "2004/06/04 05:00 [entrez]"
     ],
     "AID": [
          "10.1037/0735-7044.118.3.563 [doi]",
          "2004-95232-012 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Behav Neurosci. 2004 Jun;118(3):563-8. doi: 10.1037/0735-7044.118.3.563.",
     "term": "hippocampus"
}